EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lc—ms-based untargeted metabolomics reveals potential mechanisms of histologic chronic inflammation promoting prostate hyperplasia

Jiale Li iD, Beiwen Wu, Guorui Fan, Jie Huang, Zhiguo Li, Fenghong Cao

PLOS ONE · 23.12.2024 · 19 (12) · e0314599

DOI: 10.1371/journal.pone.0314599 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 23.12.2024. Verfasst von Jiale Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Medical College, North China University of Science and Technology, Tangshan, China. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Metabolomics, Prostatitis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hebei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic prostatitis may be a risk factor for developing proliferative changes in the prostate, although the underlying mechanisms are not entirely comprehended. Materials and methods Fifty individual prostate tissues were examined in this study, consisting of 25 patients diagnosed with prostatic hyperplasia combined with histologic chronic inflammation and 25 patients diagnosed with prostatic hyperplasia alone. We employed UPLC-Q-TOF-MS-based untargeted metabolomics using ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry to identify differential metabolites that can reveal the mechanisms that underlie the promotion of prostate hyperplasia by histologic chronic inflammation. Selected differential endogenous metabolites were analyzed using bioinformatics and subjected to metabolic pathway studies.

Results

Nineteen differential metabolites, consisting of nine up-regulated and ten down-regulated, were identified between the two groups of patients. These groups included individuals with combined histologic chronic inflammation and those with prostatic hyperplasia alone. Glycerolipids, glycerophospholipids, and sphingolipids were primarily the components present. Metabolic pathway enrichment was conducted on the identified differentially expressed metabolites. Topological pathway analysis revealed the differential metabolites’ predominant involvement in sphingolipid, ether lipid, and glycerophospholipid metabolism. The metabolites involved in sphingolipid metabolism were Sphingosine, Cer (d18:1/24:1), and Phytosphingosine. The metabolites involved in ether lipid metabolism were Glycerophosphocholine and LysoPC (O-18:0/0:0). The metabolites involved in glycerophospholipid metabolism were LysoPC (P-18:0/0:0) and Glycerophosphocholine. with Impact > 0. 1 and FDR < 0. 05, the most important metabolic pathway was sphingolipid metabolism.

Conclusions

In conclusion, our findings suggest that patients with prostate hyperplasia and combined histologic chronic inflammation possess distinctive metabolic profiles. These differential metabolites appear to play a significant role in the pathogenesis of histologic chronic inflammation-induced prostate hyperplasia, primarily through the regulation of sphingolipids and glycerophospholipids metabolic pathways. The mechanism by which histologic chronic inflammation promotes prostate hyperplasia was elucidated through the analysis of small molecule metabolites. These findings support the notion that chronic prostatitis may contribute to an increased risk of prostate hyperplasia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic HyperplasiaMetabolomicsProstatitisMaleHumansAgedMiddle AgedInflammationProstateChronic DiseaseMass SpectrometryChromatography, LiquidSphingolipidsMetabolic Networks and PathwaysGlycerophospholipidsLiquid Chromatography-Mass Spectrometry

Substanzen

SphingolipidsGlycerophospholipids

Autor:innen und Institutionen

  • Clinical Medical College, North China University of Science and Technology, Tangshan, China.
  • The Hebei Key Lab for Organ Fibrosis, The Hebei Key Lab for Chronic Disease, School of Public Health, International Science and Technology Cooperation Base of Geriatric Medicine, North China University of Science and Te…

ORCID-Profile: Jiale Li

Förderung

  • Natural Science Foundation of Hebei Province

Zitieren

APA

Li, J., Wu, B., Fan, G., Huang, J., Li, Z., & Cao, F. (2024). Lc—ms-based untargeted metabolomics reveals potential mechanisms of histologic chronic inflammation promoting prostate hyperplasia. PLOS ONE, 19(12), e0314599. https://doi.org/10.1371/journal.pone.0314599

Vancouver

Li J, Wu B, Fan G, Huang J, Li Z, Cao F. Lc—ms-based untargeted metabolomics reveals potential mechanisms of histologic chronic inflammation promoting prostate hyperplasia. PLOS ONE. 2024;19(12):e0314599. doi:10.1371/journal.pone.0314599

BibTeX
@article{Li2024,
  author = {Li, Jiale and Wu, Beiwen and Fan, Guorui and Huang, Jie and Li, Zhiguo and Cao, Fenghong},
  title = {Lc—ms-based untargeted metabolomics reveals potential mechanisms of histologic chronic inflammation promoting prostate hyperplasia},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {12},
  pages = {e0314599},
  doi = {10.1371/journal.pone.0314599}
}
Kostenlos starten →